Chemoinformaics analysis of Abieta-6,8,11,13-tetraen-12-yl acetate
| Molecular Weight | 326.48 | nRot | 2 |
| Heavy Atom Molecular Weight | 296.24 | nRig | 17 |
| Exact Molecular Weight | 326.225 | nRing | 3 |
| Solubility: LogS | -6.789 | nHRing | 0 |
| Solubility: LogP | 5.998 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 58.3478 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.503 |
| Synth | 3.751 |
| Natural Product Likeliness | 2.141 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.002 |
| HIA | 0.042 |
| CACO-2 | -5.269 |
| MDCK | 0.0000142 |
| BBB | 0.258 |
| PPB | 0.9933 |
| VDSS | 1.202 |
| FU | 0.0418 |
| CYP1A2-inh | 0.315 |
| CYP1A2-sub | 0.558 |
| CYP2c19-inh | 0.484 |
| CYP2c19-sub | 0.925 |
| CYP2c9-inh | 0.337 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.129 |
| CYP2d6-sub | 0.688 |
| CYP3a4-inh | 0.528 |
| CYP3a4-sub | 0.58 |
| CL | 2.393 |
| T12 | 0.063 |
| hERG | 0.106 |
| Ames | 0.023 |
| ROA | 0.448 |
| SkinSen | 0.578 |
| Carcinogencity | 0.139 |
| EI | 0.507 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.814 |
| Antiviral | No |
| Prediction | 0.783194 |